Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome

Abstract

Irritable bowel syndrome was shown to impose an economic burden on the Medicaid program. The cost of treating patients with irritable bowel syndrome is higher than the cost of treating matched ambulatory Medicaid recipients without the condition.